Paper2969232
Thiamine and Alzheimer's disease. A pilot study.
Blass JP and 4 others. Arch Neurol, 1988. Cited by 66 papers, by iCite.
Cite this record
ConductScience Library. Thiamine and Alzheimer's disease. A pilot study. Papers, record 2969232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2969232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Thiamine | Major topic |
| Behavior | |
| Cognition | |
| Double-Blind Method | |
| Humans | |
| Mental Status Schedule | |
| Niacinamide | |
| Pilot Projects |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| AG 03853 | NIA NIH HHS | United States | P01AG003853 | PubMed and NIH |
Source NIH RePORTER
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41769656 | Vitamin deficiencies and Alzheimer's disease: evidence and implications for supplementation. | Front Nutr | 2026 | https://conductscience.org/library/papers/41769656 | PubMed |
| 38379897 | Emerging antioxidant therapies in Friedreich's ataxia. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38379897 | PubMed |
| 36275801 | Pharmacological thiamine levels as a therapeutic approach in Alzheimer's disease. | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/36275801 | PubMed |
| 35750148 | Alzheimer's disease is associated with disruption in thiamin transport physiology: A potential role for neuroinflammation. | Neurobiol Dis | 2022 | https://conductscience.org/library/papers/35750148 | PubMed |
| 34337137 | Supplemental thiamine as a practical, potential way to prevent Alzheimer's disease from commencing. | Alzheimers Dement (N Y) | 2021 | https://conductscience.org/library/papers/34337137 | PubMed |
| 34063830 | Neuroprotective Effects of Thiamine and Precursors with Higher Bioavailability: Focus on Benfotiamine and Dibenzoylthiamine. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34063830 | PubMed |
| 33867932 | Severe Spinal Cord Injury in Rats Induces Chronic Changes in the Spinal Cord and Cerebral Cortex Metabolism, Adjusted by Thiamine That Improves Locomotor Performance. | Front Mol Neurosci | 2021 | https://conductscience.org/library/papers/33867932 | PubMed |
| 32503628 | Parenteral thiamine for prevention and treatment of delirium in critically ill adults: a systematic review protocol. | Syst Rev | 2020 | https://conductscience.org/library/papers/32503628 | PubMed |
| 32351968 | Malnutrition, Health and the Role of Machine Learning in Clinical Setting. | Front Nutr | 2020 | https://conductscience.org/library/papers/32351968 | PubMed |
| 29860433 | Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy. | Hum Mol Genet | 2018 | https://conductscience.org/library/papers/29860433 | PubMed |
| 27696179 | Long-Term Cognitive Improvement After Benfotiamine Administration in Patients with Alzheimer's Disease. | Neurosci Bull | 2016 | https://conductscience.org/library/papers/27696179 | PubMed |
| 27596507 | Thiamine Deficiency and Neurodegeneration: the Interplay Among Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy. | Mol Neurobiol | 2017 | https://conductscience.org/library/papers/27596507 | PubMed |
| 26971083 | Vitamin B1 (thiamine) and dementia. | Ann N Y Acad Sci | 2016 | https://conductscience.org/library/papers/26971083 | PubMed |
| 26212886 | Molecular mechanisms of the non-coenzyme action of thiamin in brain: biochemical, structural and pathway analysis. | Sci Rep | 2015 | https://conductscience.org/library/papers/26212886 | PubMed |
| 25346723 | Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease. | Front Endocrinol (Lausanne) | 2014 | https://conductscience.org/library/papers/25346723 | PubMed |
| 22982063 | Abnormal thiamine-dependent processes in Alzheimer's Disease. Lessons from diabetes. | Mol Cell Neurosci | 2013 | https://conductscience.org/library/papers/22982063 | PubMed |
| 22305197 | Pharmacokinetics of high-dose oral thiamine hydrochloride in healthy subjects. | BMC Clin Pharmacol | 2012 | https://conductscience.org/library/papers/22305197 | PubMed |
| 22218733 | Role of thiamine in Alzheimer's disease. | Am J Alzheimers Dis Other Demen | 2011 | https://conductscience.org/library/papers/22218733 | PubMed |
| 20463407 | A mitocentric view of Alzheimer's disease suggests multi-faceted treatments. | J Alzheimers Dis | 2010 | https://conductscience.org/library/papers/20463407 | PubMed |
| 18437212 | Potent radical-scavenging activities of thiamin and thiamin diphosphate. | J Clin Biochem Nutr | 2007 | https://conductscience.org/library/papers/18437212 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2969232
GET https://conductscience.org/api/papers/v1/2969232/cited_by?page=2